ACTA NEUROCHIRURGICA-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2024-06-23 pretecrice 来自北京

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：脑卒中;神经外科
经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2024-06-20 扎西格桑来自亚太地区

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：神经外科罕见病
经验分享：一篇case罕见病，投了2个月了，依然是with editor

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2023-12-19 ms9000000499364981 来自山东省

审稿速度:2.0 | 投稿命中率:95.0
经验分享：1个多月给了大修，一周多修回，又过了半月直接接收

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2022-04-19 ms2000001491918846

有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里

73 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2022-06-08 14692289m17暂无昵称

请问下有该杂志有没提供投稿的模板

67 0

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

什么是correspondingauthor/通讯作者？

82 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2021-12-28 小动量

期刊可以有几个通讯作者/第一作者？

72 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2020-07-17 L小雨同学

坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。

176 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2020-05-28 小峰丰

no reviewers invited文章状态，这个该怎么办？什么意思这是？

152 0

[GetPortalCommentsPageByObjectIdResponse(id=2211250, encodeId=d1292211250b1, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：脑卒中;神经外科 经验分享：投稿一个月左右给了大修，修回十多天接收，从投稿到接收差不多两个月，审稿人的意见比较专业，总的来说命中率比较高，2024年影响因子普降的情况下，这本杂志还升了一点，值得试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2e655563389, createdName=pretecrice, createdTime=Sun Jun 23 14:34:59 CST 2024, time=2024-06-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210909, encodeId=ed032210909ad, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：神经外科罕见病 经验分享：一篇case罕见病，投了2个月了，依然是with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhZH5WAjR3Ybvu2MCzSw8YOeKwr6DY4BVJ28AUrRvO4Uic5574WdsiaMmJhVJmFEjtPobBGwsTOfzWv/0, createdBy=69aa2102724, createdName=扎西格桑, createdTime=Thu Jun 20 23:37:37 CST 2024, time=2024-06-20, status=1, ipAttribution=亚太地区), GetPortalCommentsPageByObjectIdResponse(id=2175946, encodeId=98a321e59469a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：1个多月给了大修，一周多修回，又过了半月直接接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f705720594, createdName=ms9000000499364981, createdTime=Tue Dec 19 18:41:51 CST 2023, time=2023-12-19, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1212450, encodeId=b35412124502c, content=有没有人因为提交资料顺序不断的被退回呢？Please submit your paper in the following order？我已经按照顺序修改了，但是反复四五次，总是退回，反复要修改，不知道问题出在哪里, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07506397746, createdName=ms2000001491918846, createdTime=Tue Apr 19 10:36:02 CST 2022, time=2022-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225267, encodeId=16fd122526ea9, content=请问下有该杂志有没提供投稿的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8fd5149326, createdName=14692289m17暂无昵称, createdTime=Wed Jun 08 21:14:11 CST 2022, time=2022-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086033, encodeId=598910860338b, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086034, encodeId=e218108603494, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803112, encodeId=8926803112f7, content=坑人的杂志，折腾我好几个月，按照意见改的我文章面目全非最后被拒稿，各位同道们慎投吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEL4QH3jCCAcUwiaHgYl2S3DBxE5icMcquyibajfk4v65QQpibxMEGcLrqoNBMhyiaTT5mAHcIPHD6eO15A/132, createdBy=fa272321734, createdName=L小雨同学, createdTime=Fri Jul 17 14:50:53 CST 2020, time=2020-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=600729, encodeId=62ed600e29ac, content=no reviewers invited文章状态，这个该怎么办？什么意思这是？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Thu May 28 16:44:21 CST 2020, time=2020-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586146, encodeId=5b7258614666, content=这个杂志的论著审稿时间比个案，解剖什么的长一些吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=175, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73a92476439, createdName=小峰丰, createdTime=Sun Mar 08 00:00:00 CST 2020, time=2020-03-08, status=1, ipAttribution=)]

2020-03-08 小峰丰

这个杂志的论著审稿时间比个案，解剖什么的长一些吧

175 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务